|
Dec 21
|
Chief Development Officer Darlene Noci Sells 40,000 Shares of Nuvalent Inc (NUVL)
|
|
Dec 21
|
Nuvalent to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Sep 18
|
Nuvalent to Present Preliminary Data from ALKOVE-1 Phase 1/2 Clinical Trial of NVL-655 at 35th AACR-NCI-EORTC Symposium
|
|
Sep 10
|
We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely
|